#hiv testing in india

[dshseodelhi]

The Role of DrSafeHands in India’s HIV Testing Landscape: Quality and Accessibility

India has made significant strides in its fight against HIV/AIDS over the years, but the battle is far from won. With a large and diverse population, addressing the HIV epidemic remains a formidable challenge. Central to this challenge is ensuring that HIV testing is both of high quality and accessible to all those who need it. In this context, DrSafeHands, a pioneering healthcare organization, has emerged as a crucial player in India’s HIV testing landscape, contributing significantly to both quality and accessibility.

Quality in HIV Testing

Quality is a paramount concern in HIV testing. Inaccurate or unreliable test results can lead to misdiagnosis, delayed treatment, and the further spread of the virus. DrSafeHands places a strong emphasis on quality control and assurance in its HIV testing services.

Accurate Tests: DrSafeHands employs state-of-the-art testing methods, including the use of rapid antibody tests, nucleic acid tests (NAT), and enzyme-linked immunosorbent assays (ELISA) to ensure accurate and reliable results.

Skilled Professionals: The organization employs a team of highly trained and certified healthcare professionals who administer tests with precision and care.

Stringent Protocols: Stringent protocols for sample collection, storage, and transport are followed to prevent contamination and ensure the integrity of the samples.

Data Privacy: DrSafeHands prioritizes data privacy and ensures that all patient information is kept confidential, in compliance with legal and ethical standards.

Accessibility in HIV Testing

Accessibility is equally crucial in the fight against HIV. India’s diverse population, coupled with social and economic disparities, demands innovative solutions to ensure that HIV testing is available to everyone.

Mobile Clinics: DrSafeHands has pioneered the concept of mobile clinics, reaching underserved populations in rural and remote areas. These clinics offer counseling and testing services, breaking down geographical barriers to access.

Home Testing Kits: Recognizing the importance of privacy and convenience, DrSafeHands offers home testing kits, allowing individuals to test themselves discreetly and conveniently.

Affordability: The organization is committed to making testing affordable. DrSafeHands offers low-cost and subsidized testing options, ensuring that financial constraints do not deter individuals from getting tested.

Telemedicine: DrSafeHands leverages telemedicine to provide counseling and support services to those unable to visit physical clinics. This approach not only enhances accessibility but also reduces the stigma associated with HIV testing.

Community Engagement

DrSafeHands goes beyond testing by actively engaging with communities. It conducts awareness campaigns, educational programs, and outreach activities to reduce the stigma surrounding HIV/AIDS. By fostering an open dialogue, the organization encourages individuals to get tested and seek treatment without fear of discrimination.

Collaboration and Advocacy

Recognizing that addressing HIV/AIDS requires a collective effort, DrSafeHands collaborates with government agencies, NGOs, and international organizations to strengthen the overall response to the epidemic. It advocates for policies that promote HIV testing and treatment, aiming for a more inclusive and comprehensive healthcare system.

Conclusion

In India’s ongoing battle against HIV/AIDS, ensuring the quality and accessibility of testing services is paramount. DrSafeHands has emerged as a vital player in this endeavor, offering accurate testing, breaking down barriers to access, and actively engaging with communities. By prioritizing quality, accessibility, community engagement, and collaboration, DrSafeHands is making significant strides in India’s fight against HIV/AIDS, bringing us one step closer to an HIV-free nation.

[drmongamediclinicdelhincr]

Best HIV Doctor near Rohini, Delhi Call 8010977000

Talk online/offline with an HIV specialist in Rohini, Delhi, Book an appointment at +91- 9999219128,8010977000 to get PrEP treatment near me.

Full Stack Care - Consultation Diagnosis & Treatment. HIV Services, PEP/PrEP Solutions.

‎24X7 HIV Support · ‎PEP for HIV · ‎About Us · ‎Locations · ‎ART Drugs for HIV · ‎PEP Treatment for HIV in Delhi NCR.

[aveconhealthcare-blog]

Avecon Healthcare is a top leading biotechnology company, Hiv Test Kit Manufacturers India is a highly accurate, reliable, fast, and convenient in use.

[pathologylab]

Our Rapi-Q Rapid #POCT is a compact device with a combination of precision and speed that processes up to 8 samples in less than 45 minutes. It is a complete solution for multiple #disease detection powered by Software driven automated analysis. Accelerate #Diagnosis for multiple detections with #Genes2Me Rapi-Q!

To know more visit. https://t2m.io/rapi-q-poc-rtpcr

For more details, Call us at 18001214030 or drop us an email at social@genes2me.com

#poc #pointofcare #pointofcaretesting #diagnostic #manufacturer #madeinindia #testing #machines #hiv #hpv #highaccuracy #instrument #rapidtest #rtpcr #pcrtesting #pcr #health #healthcare #detection #genetic

[afeelgoodblog]

The Best News of Last Week - March 20, 2023

🌱 - Okra to the Rescue and Other News You Can't 'Lettuce' Miss This Week

1. 4 day work week being pushed in Congress

Progressive Democrats, led by Rep. Mark Takano of California, are pushing for a four-day workweek to give Americans more time for leisure outside of work. The proposed Thirty-Two Hour Workweek Act would amend the Fair Labor Standards Act of 1938 to require overtime pay for any employee working more than 32 hours in a week at a rate of time and a half.

More than 70 British companies have started to test a four-day workweek, and halfway through the six-month trial, most respondents reported there has been no loss in productivity.

2. Governor Walz signs universal school meals bill into Minnesota law

Minnesota just became the fourth state in the US to provide breakfasts and lunches at no charge to students at participating schools! The bill was signed into law by Governor Tim Walz on Friday, and it's set to ease the burden on parents who struggle to provide meals for their children.

The new legislation will cover the cost of meals for all students, regardless of household income. This means that families who don't qualify for free and reduced meals but who struggle to pay for food will also be covered. The bill is also meant to prevent "lunch shaming" practices, where children are denied food or given substitutes that indicate their family is struggling financially.

3. Texas Researchers Use Okra to Remove Microplastics from Wastewater

Researchers from Tarleton State University in Fort Worth, Texas discovered that food-grade plant extracts from okra have the power to remove microplastics from wastewater. Polysaccharide extracts from plants like fenugreek, cactus, aloe vera, tamarind, and okra were found to be effective non-toxic flocculant alternatives to remove microplastics from water.

Polysaccharides from okra and fenugreek were best for removing microplastics from ocean water, while a combination of okra and tamarind worked best for freshwater. Furthermore, plant-based flocculants can be easily implemented in existing water treatment facilities.

4. In the northern California snow, stranded cows are getting emergency hay drops

The recent wave of unprecedented snowfall in California has left cattle stranded and starving. When rancher Robert Puga ran out of hay, neighboring Humboldt County officials put together an emergency rescue operation called "Operation Hay Drop." State, federal, and local officials airdropped stranded cattle bales of hay to feed them.

Humboldt County Sheriff William Honsal went to the Coast Guard with the idea of a helicopter rescue, and by midday Sunday, March 5, Operation Hay Drop was underway. So far, Operation Hay Drop has been a success, said rancher Puga. The mission covers about 2,500 head of cattle over several miles.

5. Make-A-Wish Foundation no longer considers Cystic Fibrosis to be automatically qualifying due to improvements in life outcomes for patients

Given the ongoing life-changing advances in cystic fibrosis, beginning in January 2024, cystic fibrosis will no longer automatically qualify for a wish.

6. 1st woman given stem cell transplant to cure HIV is still virus-free 5 years later

In 2017, a woman known as the "New York patient" underwent a stem cell transplant to treat both her cancer and HIV. Now, about 30 months later, she has been virus-free and off her HIV medication, leading some researchers to suggest that she may have been cured of HIV.

The New York patient, received stem cells taken from umbilical cord blood that also had the HIV-resistance genes. However, it's important to note that there is no official distinction between being cured and being in long-term remission, and the medical team is waiting for longer-term follow-up before making any definitive statements.

7. Cheetahs Back in Wild in India After Seven Decades

Namibian cheetahs have been successfully reintroduced to India after the world's fastest land animal was declared extinct in the South Asian country more than 70 years ago. Two cheetahs, Obaan and Asha, were released into the wild of Kuno National Park after being brought to India last September.

The species is being reintroduced on an experimental basis as part of a major prestige project for Prime Minister Narendra Modi. India aims to bring in about 100 of the big cats over the next decade. The African cheetah is a different subspecies from the extinct Asiatic cheetah, which once roamed the sub-continent in great numbers.

Lastly, I recently opened a Youtube channel. Subscribe for a weekly compilation of feel good videos.

- - -

That's it for this week :) If you liked this post you can support me with a small kofi donation:

Buy me a coffee ❤️

Let's carry the positivity into next week and keep spreading the good news!

[covid-safer-hotties]

Also preserved in our archive

by Hannah Buttle

Editor’s note: This article contains a brief mention of suicidal ideation.

Key points you should know:

There are currently no approved treatments for Long COVID and progress on clinical trials has been slow. Some medications can improve people’s quality of life, but they may not work for everyone.

With few choices, rejected disability claims, financial instability, and little support, some people with the disease have turned to online pharmacies, often based in India, to source potential medications.

Popular choices include medications used to treat conditions like HIV, hepatitis C, and acute COVID-19. Some of these drugs are being tested in upcoming clinical trials for Long COVID.

Buying medications online from unknown sellers can be risky; buyers might not receive the correct medication or even receive something harmful.

However, many people with Long COVID feel their quality of life has declined so severely that these risks are worth taking. With no approved treatments, lack of support, and stigma against the disease, many people with Long COVID are using overseas pharmacies to source medications. Some of these treatments are widely used for other conditions, such as HIV and hepatitis C, but are not approved for use in Long COVID.

“I was in such a desperate situation,” said Rafael, who lives in the U.K. and developed Long COVID in 2021. “I was bedbound, and I was within months of losing my job, which would then mean losing my home. So I didn’t have much to lose.”

Rafael bought several months’ worth of Maraviroc, an HIV drug, from a seller in India via WhatsApp. Soon after taking the Maraviroc, Rafael had a significant improvement in symptoms, although he was taking other medications at the same time.

“If I wasn’t so debilitated by Long COVID, I probably wouldn’t have taken the risk,” Rafael said.

The Sick Times spoke to several people with Long COVID who had used online pharmacies to import medications from abroad. Because importing medication can be illegal in certain circumstances, many sources interviewed for this article asked to be identified by their first name only or by a pseudonym.

Popular choices for people with Long COVID included the acute COVID-19 antiviral Paxlovid, the HIV drugs Maraviroc and Truvada, and the hepatitis C drug Sofosbuvir. Maraviroc and Truvada are currently being evaluated in an upcoming clinical trial at the Cohen Center for Recovery from Complex Chronic Illness, but results are not expected until at least early 2026.

Some people with Long COVID find some relief with off-label medications like low-dose naltrexone, but many told The Sick Times their doctors won’t prescribe these treatments. Even when doctors are willing to consider off-label treatments, health insurance often will not cover them.

Few treatments in sight The slow progress on clinical trials for Long COVID has been a source of frustration for both researchers and patients. The pharmaceutical industry has expressed little interest in finding treatments for the disease. Studies through the RECOVER initiative, launched by the U.S. National Institutes of Health (NIH), have primarily focused on observational approaches, such as asking people with Long COVID to track their symptoms, though the initiative is now planning new trials.

An analysis by The Sick Times found that fewer than a quarter of clinical trials for Long COVID are drug interventions, as of November 2024.

(interactive graph here)

Even when clinical trials take place, there is no guarantee of a “one-size-fits-all” treatment for Long COVID, said Ondine Sherwood, CEO of Long COVID SOS, a charity in the U.K. representing people with the disease. Currently, the available drugs may help only with specific symptoms or may work only for certain subsets of people with Long COVID.

Given the severity of symptoms and widespread government abandonment, it is unsurprising that some people with Long COVID have taken risks to seek relief from their symptoms since the beginning of the pandemic. Past unapproved treatments have included HELP apheresis, an expensive procedure that removes blood from a vein, filters the blood, and returns the filtered blood to the body. Many have also tried triple anticoagulant therapy, in which patients take aspirin, clopidogrel, and a blood thinner like Apixaban to break down small blood clots, called microclots. There is a high bleeding risk associated with triple anticoagulant therapy.

For many people with Long COVID, however, anything that offers a chance of improvement may seem worthwhile. Survey data suggest that the quality of life of someone with Long COVID can be worse than that of someone with stage four cancer. People with Long COVID may also be at a higher risk for suicidal ideation.

Financial insecurity can also drive people with Long COVID to consider experimental treatments, as many are out of work, behind on housing payments, and facing other financial challenges.

Some doctors may be willing to prescribe medications off-label for Long COVID and related conditions, like dysautonomia and mast cell activation syndrome (MCAS). Commonly prescribed drugs include beta-blockers, which lower heart rate, for dysautonomia, or H1 and H2 antihistamines for MCAS.

Dysautonomia drugs can lead to “massive improvement” for some, said Dr. Asad Khan, who worked as a respiratory doctor in the U.K. before developing Long COVID. For example, a beta blocker could bring down a patient’s heart rate while posing a limited risk, he said.

But some off-label treatments could carry higher risks, especially without a doctor’s oversight, said Khan: “You've got people taking anticoagulants and various other drugs that can affect the kidney, and the liver, and can have effects on the nervous system, and nobody's monitoring. The problems could be quite serious, and it could even be fatal.”

However, doing nothing for a patient can also put them in danger, said Khan. For instance, some research indicates that COVID-19 can lead to a higher risk of heart attacks and strokes for years after the infection.

People with Long COVID echoed these concerns. “I worry that, the longer we wait, the higher the destruction in our bodies,” said Lena, from Germany, who has had the disease since 2021.

After a difficult few months of symptoms, Lena decided to buy a generic form of Truvada, an HIV medication, through an online pharmacy. While she was scared, “pure despair” led her to try the medication, she said.

“I was having suicidal ideation,” she said. “If you have to weigh up how I was feeling versus taking an unknown pill, there’s no contest.” Many people with Long COVID who spoke to The Sick Times felt that buying medication online was their only choice.

How online pharmacies work Without a doctor to recommend the correct drug and dosage, many people with Long COVID receive advice from online social media groups. Users share tips on which drugs had worked for them, how to slowly increase the dosage of medications, and which side effects to expect.

Most of those interviewed by The Sick Times reported purchasing drugs without a prescription, either from national online pharmacies or from India via services like IndiaMart, an online marketplace. India is the world's largest exporter of generic pharmaceuticals.

“For me, what helped was a combination of ten days of Paxlovid and Sofosbuvir,” an antiviral drug for hepatitis C, said Tiff, from the U.S., who developed Long COVID in 2020. Tiff had read online about other people finding relief from the disease with these medications. She asked a friend to bring them back from India and had a significant decline in symptoms.

“I felt like I did pre-2020,” she said. “I had energy. I felt wonderful. No [Post-exertional malaise (PEM)] crash, no brain fog, no symptoms, nothing.” Tiff was later reinfected with SARS-C0V-2, and her Long COVID symptoms returned. She once again bought Sofosbuvir and Paxlovid from a seller in India and saw an improvement.

Lower prices offer another incentive to buy medications from abroad. Take Paxlovid, which can cost as much as $1,400 for a five-day course in the U.S., while a generic version from India costs just $103.

Sofia lives in Austria and has Long COVID. “In Austria, it would cost €40,000 for four months of Sofosbuvir,” she said, which “would be unaffordable.”

An anonymous Twitter/X user offered to help Sofia. She sent him €200, and he bought the medication in India and took it back to Europe. Since taking the Sofosbuvir, Sofia said she went from 40% to 60% of her previous level of functioning.

Risks and regulations Generic medications in the U.S., U.K., and Europe are commonly exported from India. But those exported through official channels are often subject to stricter regulatory standards than the medications available to locals. For those who have bought medications online from abroad, confirming the medications are safe can be difficult.

“We don’t have a functional regulatory system in India,” said Dinesh Thakur, a drug-safety advocate and former pharmaceutical executive. Online markets like IndiaMart have no safety guarantee.

“In the best-case scenario, the product may not contain enough of the active ingredient,” he said. “In the worst-case scenario, an injectable may contain endotoxins [harmful substances released by bacteria].”

If buyers from outside India have a bad experience, it would be difficult to hold a foreign company to account, Thakur added.

Nonetheless, many who spoke to The Sick Times felt that, despite the risks involved, they had to try something to relieve their symptoms.

“The symptoms grind you down so much, the risk calculus changes,” said Chris, from the UK, who has had Long COVID since 2020. “There is no help coming, nothing on the horizon.”

The World Health Organization has a checklist for gauging the safety of medicines purchased online. Tips include looking out for unusual activity on your credit card, checking security seals, and ensuring the batch number and expiry date on the package match throughout.

People with Long COVID may also be able to access off-label medications from more reliable sources. For instance, some online clinics may prescribe medications after a consultation. RTHM, a U.S.-based online clinic, offers a prescribing service for certain off-label medications for Long COVID, including low-dose naltrexone, beta-blockers for dysautonomia, and ketotifen for MCAS. In the U.K., those with a confirmed diagnosis of Long COVID or ME can buy low-dose naltrexone through Dicksons Chemist.

Another option for a small number of those with Long COVID is to join a clinical trial — though depending on the trial’s setup, some participants may receive a placebo instead of a drug.

Without the oversight of a pharmacist, taking a DIY approach to medications could also lead to dangerous medication interactions, even when the drugs are high quality. Paxlovid, for example, interacts with many drugs people take for Long COVID. These include ivabradine, some statins, and HIV medications. The University of Liverpool offers a COVID-19 drug interactions checker, which could help those using drugs like Paxlovid.

Regular blood tests could also help monitor for side effects. Truvada and Maraviroc can increase liver enzymes, and patients who take these medications for HIV prevention and HIV are advised to monitor liver enzymes regularly. Rafael, who bought Maraviroc, said he received monthly liver checks while taking the drug. These tests, which individuals can do privately without a GP referral, cost around £50 ($60) in the U.K.

Even if medications are safe, they are not guaranteed to work. People with Long COVID risk spending hundreds to thousands of dollars without success. New drugs could also lead to worse symptoms and significantly worsen a person’s health baseline.

Chris tried several medications, including Maraviroc and blood thinners, but has seen few improvements in symptoms. “You end up becoming your own guinea pig because nothing else is happening,” he said.

“It’s easy to depict people as reckless and not understanding the risks. But that’s not the case at all. Everyone understands the risks —they’re doing it because they’ve got no choice.”

[lindyloosims]

Ah the twins! Just popped up out of nowhere and messed up my gameplay in a big way! Patriarch had the Eternally Faithful trait that comes with Wicked Whims, which means he will not stray from his spouse AT ALL!!! Well guess what? These two contradict that trait in a big way, Lilith managed to squeeze out two tadpoles from his testes and produced these two! How? You tell me, you leave to go to another save and this is what happens! Yeah!

So eighth born Jonah, the human twin, was a sweet little thing who was lucky enough to get daddy in the custody battle! Both Jonah and his twin sister hated Lilith with a passion for some reason but loved their Uncle Caleb. Jonah also adored his dad and stepmother (which will become ick soon) and he loved living in Sulani with them. As far as other siblings go, Jonah got along with most of them, but as soon as his dad stole India from their mother (she came for a custody visit and he just never gave her back), Jonah was glued to her. As twins they had a special bond that no other sibling had with them. He had the mummy dearest and daddy dearest sentiments for his father and stepmother, he really did love them both and if you ask him he’ll tell you that his childhood was a happy one. His young adulthood is where it gets icky and sad, his father died at the hands of a killer rabbit while my back was turned in another household, and he lost his twin sister as a young adult too. With dad gone, he and his stepmother fell for each other and were soon frolicking under the covers which resulted in a pregnancy. Now as I stated before, she never really got over his father and poor Jonah was always second best. Ghost daddy seduced stepmother-girlfriend after baby Bonnie was born, breaking Jonah’s poor heart, but he was determined to put a ring on that finger and after a lot of persistence, Jonah got his girl...or did he? They had baby Boyd shortly after the wedding, but ghost daddy is never too far away and continues to mess around with his widow who’s now married to his son and gave birth to his grandchildren! Confused? You will be!

Chaotic Fact: Where do you want me to start? Was the above not enough? Oh he’s erratic FYI, so that’s fun!

Onto India the vampire twin, ninth born, and very tragic young woman! She was evil, hated children and often had negative moodlets around her younger siblings. She moved into eldest sister Kenzie’s old sex dungeon with Ronen Feng and Camden Kealoha. Another sandwich situation ensued and the boys would pass her around each other a lot, but she married Camden, only to discover she was carrying Ronen’s child. Ronen was diagnosed with HIV so the whole house went and got tested, luckily they were clean. Baby Kailee was born and India still hated children, so it was up to Camden and Ronen to take care of the baby. One fateful day she visited her brother and stepmother in Sulani only to succumb to the sunshine and die in the sea! So sad! Such a short and uneventful life which is why I don’t have a picture of her as a young adult because she died so suddenly! Maybe she would have grown to love Kailee, maybe not! Camden and Ronen, who are on and off lovers, now take care of her together like they always did.

Chaotic Fact: India had the “sensually tight” trait from Wicked Whims and that was great fun, not for her but Camden and Ronen certainly enjoyed it! Poor girl lived a life of pain and hatred, RIP!

[leodiagnostics01]

Discover Comprehensive Diagnostic Services at Leo Diagnostics

When it comes to diagnostic healthcare, Leo Diagnostics is your trusted partner for precision, reliability, and quality. As a leading diagnostic service provider in India, we are dedicated to enhancing healthcare outcomes for individuals and families. Located in Wakad, Pimpri-Chinchwad, and Pune, we are committed to meeting the unique healthcare needs of our communities with excellence.

About Leo Diagnostics

Leo Diagnostics is a state-of-the-art diagnostic service provider offering a wide range of medical tests. Our mission is to provide accurate diagnostics, timely results, and exceptional patient care. Equipped with fully automated technology and a team of skilled professionals, we ensure every test meets the highest standards of quality and reliability.

Our Comprehensive Test Offerings

Leo Diagnostics provides a broad spectrum of diagnostic services tailored to address various health concerns. Our test offerings include:

Hematology: Comprehensive blood analysis to diagnose and monitor health conditions effectively.

Biochemistry: Advanced tests for evaluating organ function and detecting metabolic disorders.

Serology: Accurate detection of infections through antibody and antigen testing.

Immunoassays: Specialized hormonal and protein marker tests for precise health monitoring.

Clinical Pathology: In-depth fluid analysis for disease diagnosis.

Microbiology: Identification and management of infectious agents.

Histopathology: Detailed tissue examinations to diagnose diseases accurately.

LFT Blood Test in Wakad: Liver function testing to assess and maintain liver health.

Vitamin Test in Wakad: Comprehensive testing to identify vitamin deficiencies and support overall wellness.

HIV Test in Wakad: Confidential and accurate testing for early detection and management of HIV.

Complete Blood Count in Wakad: Essential blood tests to monitor overall health and detect potential illnesses.

These tests are designed to deliver reliable and quick results, ensuring timely interventions and better health outcomes.

Why Choose Leo Diagnostics?

Cutting-Edge Technology: We use the latest automation and advanced equipment to deliver precise results.

Accessibility: Our strategically located collection centers in Wakad, Pimpri-Chinchwad, and Pune provide convenience and efficiency.

Patient-Centric Services: From preventive screenings to personalized wellness packages, we prioritize your health.

Expert Care: Our team of skilled technicians and healthcare professionals ensures a seamless diagnostic experience.

Preventive Healthcare at Leo Diagnostics

At Leo Diagnostics, we strongly advocate for preventive healthcare. Regular health check-ups and screenings play a vital role in detecting potential health issues early. Our preventive healthcare packages are tailored to meet the diverse needs of individuals, helping you stay ahead in your wellness journey.

State-of-the-Art Facilities

Our laboratory features advanced diagnostic technology and adheres to stringent quality control protocols. From sample collection to reporting, every process is meticulously managed to ensure accuracy and reliability.

Convenient and Accessible Services

With a network of collection centers across Wakad, Pimpri-Chinchwad, and Pune, we make it easy for you to access our services. Whether you need a routine test or specialized diagnostics, Leo Diagnostics is here to assist you.

Partner with Leo Diagnostics Today

Leo Diagnostics is dedicated to empowering communities with reliable diagnostic solutions. By offering advanced medical testing and personalized care, we aim to support your journey to optimal health. Trust us to deliver the accuracy and service you deserve.

Visit us at our centers in Wakad, Pimpri-Chinchwad, and Pune to experience diagnostic excellence. Your health is our priority, and we are here to walk with you every step of the way.

[snehalblog]

Latent TB Testing Market: Key Developments Shaping the Future of Tuberculosis Diagnosis

According to a new report by UnivDatos Market Insights, The Latent TB Testing Market was valued at approximately USD 1.4 Billion in 2023 and is expected to grow at a substantial CAGR of around 7.8% during the forecast period (2024-2032). Latent TB Testing determines individuals with asymptomatic Mycobacterium tuberculosis infection who are likely to develop overt TB. Screening tests include the Tuberculin Skin Test (TST) and Interferon Gamma Release Assays (IGRAs), which identify a body’s reaction to the bacteria. These tests are important in the prevention of TB epidemics among multiple risk groups such as the immunocompromised as well as the healthcare givers. This is mainly due to the increasing rates of tuberculosis across the world increasing the need to detect latent TB to prevent active TB. Also, improvements in diagnostic tools like IGRAs increase the effectiveness and utilization in high-risk groups. In addition, TB control campaigns supported by the government and compulsory screening norms also contribute to the growth of the market.

Request To Download Sample of This Strategic Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=68927&utm_source=LinkSJ&utm_medium=Snehal&utm_campaign=Snehal&utm_id=snehal

On November 25 2023, Revvity, a global company that leverages innovation in Diagnostics and Life Sciences announced the country launch of its T-SPOT.TB test for latent TB screening, at MICROCON in Lucknow.

In March 2022, PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovating for a healthier world, announced that the Company has completed its previously announced acquisition of Oxford Immunotec Global PLC (Oxford Immunotec). PerkinElmer originally announced its intent to acquire Oxford Immunotec on January 7, 2021.

Segments that transform the industry

·         Based on application, the market is segmented into household contacts (HHC) of tuberculosis (TB) patients, people living with HIV (PLHIV), and others. People living with HIV are expected to grow with a significant CAGR during the forecast period (2024-2032). The PLHIV segment is one of the primary consumers in the latent TB testing market because such patients have a higher risk of developing active TB and, therefore, require regular and accurate tests. The recent expansion of tuberculosis diagnostics in HIV care programs worldwide has boosted the need for gender-precise and accurate tests such as IGRAs. Companies adopt by developing partnerships with HIV clinics and NGOs to deliver specific test solutions and by providing affordable easy-to-scale testing solutions to this risky group.

For More Informative Information, Please Visit Us- https://univdatos.com/get-a-free-sample-form-php/?product_id=68927&utm_source=LinkSJ&utm_medium=Snehal&utm_campaign=Snehal&utm_id=snehal

According to the report, the impact of Latent TB Testing has been identified to be high for the Asia-Pacific area. Some of how this impact has been felt include:

As per the World Health Organization, In 2022, eight countries accounted for more than two-thirds of global TB cases: India (27%), Indonesia (10%), China (7.1%), the Philippines (7.0%), Pakistan (5.7%), Nigeria (4.5%), Bangladesh (3.6%) and the Democratic Republic of the Congo (3.0%).

Asia-Pacific is expected to grow with a significant CAGR during the forecast period (2024-2032). This is due to a high tuberculosis incidence rate, improved understanding of the disease, and national efforts to eliminate the disease. Adding to this, large-scale screening is being carried out in countries such as India and China with the help of international organizations. Examples include offering low-cost diagnostic solutions, forming alliances with government organizations, and increasing market coverage to areas that have limited access to the products. A shift from conventional TSTs to advanced IGRAs within the urban regions also supports the growth of the market.

[dshseodelhi]

HIV Testing By DrSafehands . For HIV Testing Visit DrSafehands Center, Online Or Please Call / WhatsApp : 9013161616 .

[drmongamediclinicdelhincr]

HIV Testing and Counselling near me Delhi NCR Call 8010977000

Talk to an HIV specialist online/offline, and book an appointment to get PrEP treatment.

Affordable HIV prevention and treatment, talk to a specialist doctor today. LGBTQIA friendly.

At Dr. Monga Clinic, we provide comprehensive HIV pre and post-testing counseling to ensure that individuals receive the necessary guidance and support during their HIV testing journey.

For expert HIV counseling and testing in Delhi, contact us at 8010977000 for more information or an appointment.

[odnewsin]

Of 8,518 tested at AIIMS Bhubaneswar in 3 months, 31 test HIV+

Bhubaneswar: The Integrated Counselling and Testing Centre (ICTC) at All India Institute of Medical Sciences (AIIMS) here has recently tested 8,518 individuals for HIV and provided counselling to 8,538 people over the past three months. Out of the tested, 31 were found HIV positive and 27 have been linked to the Anti-Retroviral Therapy (ART) Centre (ARC). Executive Director of AIIMS Bhubaneswar…

[topbestsexologistindelhi]

The most common sexual disorder in men is erectile dysfunction (ED), which is the inability to achieve or maintain an erection sufficient for sexual activity. ED can be caused by a variety of factors, including physical health conditions such as diabetes or heart disease, psychological factors such as stress or anxiety, or lifestyle factors such as smoking or excessive alcohol consumption. Other common sexual disorders in men include premature ejaculation, delayed ejaculation, and low libido. If you are experiencing any sexual dysfunction, It is vital to consult with your best sexologist in Delhi, Dr Vinod Raina, who has 25 years of experience and has treated thousands of patients.

[indipopcorn]

Should there be mandatory testing for HIV prior to marriage in India?

The Maharashtra Government proposed to make pre-nuptial HIV test mandatory. The Andhra Pradesh government, in 2006, proposed a bill to make pre-marriage HIV test compulsory. Goa is also following the same path.

Other states in India are not very keen on making pre-nuptial HIV test mandatory.

Here you should take it in to consideration the headline of Mumbai Mirror “Not informing about HIV+ status before marriage is NOT cheating, says court.”

You can imagine the life of woman after this scam and disease.  

Most of the countries that restrict entry based on HIV status.

Hindustan Times interviewed a few ladies who contracted the infection from their husbands on December 8, 2017. Since they lack education, they are ill-equipped to suggest such a test to males, they are being utilized in the world of arrange marriage. Though educated women and those from specific backgrounds can benefit from awareness, women from lower middle-class and impoverished families still have little say in marriage decisions. Therefore, these women who are in poverty will benefit from mandatory HIV testing before marriage.

It is the case in educated families as well. I have taken interview of recently married girls who are in early 20s and very few of them have undergone such a test. We talk a lot about women empowerment but marital rape, HIV test before marriage are still out of our agenda and we hesitate to discuss it and take a decision on it.

I was previously told off camera by a reputable paediatrician that I am seeing a lot of couples with HIV in upscale neighbourhoods. The Government of India estimates that about 2.40 million Indians are living with HIV (1.93 ‐3.04 million) with an adult prevalence of 0.31% (2009). Children (<15 yrs) account for 3.5% of all infections, while 83% are the in-age group 15-49 years. Of all HIV infections, 39% (930,000) are among women.

Since this illness is not common, nobody wants to jeopardise their health. It is a horrible crime in human eyes to trap someone with it until the death.

[global-research-report]

Empowering Healthcare Providers with Precision Blood Screening Tools

Blood Screening Industry Overview

The global blood screening market size is expected to reach USD 6.62 billion by 2030, registering a CAGR of 11.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the increase in screening of donor and continuous technological advancement by the market players. Demand for blood screening tests is increasing continuously due to increasing donation, rising awareness about transfusion-transmitted diseases, and technological developments in the industry. Furthermore, governments of various countries are in process to mandates testing all donated blood for several viruses.

Thorough screening is necessary for all donated blood to ensure that recipients receive the safest products. As of 2015, such testing consists of screening for red cell antibodies, and the infectious diseases agents: HIV-1, HIV-2, hepatitis virus, West Nile Virus (WNV), Human T-Lymphotropic Virus (HTLV) T. Cruzi, and T. pallidum (syphilis). The result of all these assays must be negative for blood donation.

Gather more insights about the market drivers, restrains and growth of the Blood Screening Market

Technological developments increase the sensitivity and efficiency of the tests. For instance, in 2016, the U.S. FDA approved the Procleix Zika virus assay from Hologic, Inc. and Grifols to screen donated blood. Furthermore, the U.S. FDA approved next-generation sequencing (NGS) technology in 2013. The technology is cheaper and faster than previous DNA analysis methods.

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

The global body fluid collection and diagnostics market size was estimated at USD 34.35 billion in 2024 and is projected to grow at a CAGR of 6.6% from 2025 to 2030. 

The global genetic testing market size was estimated at USD 11.71 billion in 2024 and is projected to grow at a CAGR of 22.5% from 2025 to 2030.

Blood Screening Market Segmentation

Grand View Research has segmented global blood screening market report based on technology, product, and region:

Blood Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)

Nucleic Acid Amplification Test (NAT)

ELISA

Chemiluminescence Immunoassay (CLIA & EIA )

Next Generation Sequencing (NGS)

Western Blotting (WB)

Blood Screening Product Outlook (Revenue, USD Million, 2018 - 2030)

Reagent

Instrument

Blood Screening Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

US

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Norway

Denmark

Sweden

Asia Pacific

India

Japan

China

South Korea

Australia

Thailand

Latin America

Brazil

Argentina

Middle East and Africa (MEA)

Saudi Arabia

South Africa

UAE

Kuwait

Key Companies profiled:

Abbott

Danaher Corporation (Beckman Coulter)

Becton Dickinson and Company

Bio-Rad Laboratories, Inc.

Hoffman-La Roche Ltd.

Grifols, S.A.

Ortho-Clinical Diagnostics, Inc.

Siemens Healthcare GmbH

Thermo Fisher Scientific, Inc.

SOFINA s.a (Biomerieux)

Key Blood Screening Company Insights

Some of the key companies in the market include Bio-Rad Laboratories, Inc., Hoffman-La Roche Ltd., Grifols, S.A., and others. These companies adopt strategies such as strategic collaborations to enhance innovation, mergers, and acquisitions to expand capabilities, and new product launches to address evolving healthcare needs, ensuring competitiveness and a strong market presence.

Abbott manufactures specialized medical equipment that may utilize Blood Screening components for durability and lightweight properties. Beyond blood screening, Abbott operates in various segments, including laboratory diagnostics, cardiovascular devices, diabetes care, and nutrition products, thereby enhancing its portfolio and addressing diverse healthcare needs.

Bio-Rad Laboratories, Inc. develops diagnostic instruments that may incorporate Blood Screening materials for enhanced performance and reliability in relation to Blood Screening. The company also engages in other segments, such as quality control products, gene expression analysis, and protein purification, positioning itself as a leader in both research and clinical settings.

Recent Developments

In May 2023, Siemens Healthineers launched two new analyzers, the Atellica HEMA 570 and Atellica HEMA 580, designed for high-volume hematology testing, crucial for blood screening. These advanced devices can streamline the complete blood count (CBC) process, offering rapid results and improved workflow efficiency. With the ability to process up to 120 tests per hour, these analyzers can address the growing demand for timely diagnostics in critical care settings.

Order a free sample PDF of the Blood Screening Market Intelligence Study, published by Grand View Research.